The Turin Prostate Cancer Prognostication (TPCP) is an observational cohort study sponsored by the Department of Medical Sciences of the University of Turin, funded by the AIRC Foundation for Cancer Research, and started during 2021 at the AOU Città della Salute e della Scienza di Torino.
The TPCP study aims to develop, through a new integrated approach, a prognostic model for prostate cancer that can best guide the patient’s treatment pathway.
CRS4’s role relates to fully anonymized image management and analysis of the study’s digital slides through CRS4’s Digital Pathology Platform, already the basis of international studies and research projects. In this study, in particular, the Platform will enable pathologists to examine and annotate digital slides, manually and with the support of automatic analysis tools based on artificial intelligence methods.
